Cargando…

Empowering smokers with a web-assisted tobacco intervention to use prescription smoking cessation medications: a feasibility trial

BACKGROUND: Varenicline and bupropion, efficacious smoking cessation medications, have had suboptimal impact due to barriers at the patient, practitioner and system level. This study explored the feasibility of a web-assisted tobacco intervention offering free prescription smoking cessation medicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Selby, Peter, Hussain, Sarwar, Voci, Sabrina, Zawertailo, Laurie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590254/
https://www.ncbi.nlm.nih.gov/pubmed/26429100
http://dx.doi.org/10.1186/s13012-015-0329-7
_version_ 1782392899625811968
author Selby, Peter
Hussain, Sarwar
Voci, Sabrina
Zawertailo, Laurie
author_facet Selby, Peter
Hussain, Sarwar
Voci, Sabrina
Zawertailo, Laurie
author_sort Selby, Peter
collection PubMed
description BACKGROUND: Varenicline and bupropion, efficacious smoking cessation medications, have had suboptimal impact due to barriers at the patient, practitioner and system level. This study explored the feasibility of a web-assisted tobacco intervention offering free prescription smoking cessation medication by mail if the smoker visited a physician for authorization. METHODS: Adult Ontarians, smoking at least 10 cigarettes daily, intending to quit within 30 days, with no contraindications to bupropion or varenicline were eligible. After an online assessment, eligible participants received an electronic personalized printable prescription form for a 12-week course of varenicline or bupropion to bring to a physician within 3 weeks for authorization, if appropriate. The physician’s office faxed prescriptions to an online pharmacy that couriered medication to the patient following medication counselling by telephone. Weekly motivational emails were sent during treatment. Participants were asked to complete follow-up questionnaires online at 7, 11, 15 and 41 weeks after enrollment. RESULTS: In total, 1214 individuals submitted an online assessment from April to September 2010 and 73.6 % (95 % confidence interval (CI) = 71.1–76.1 %; n = 893) were eligible. At least 65.8 % (95 % CI = 62.7–68.9 %; n = 588) of eligible participants subsequently visited a physician and 58.7 % (95 % CI = 55.5–61.9 %; n = 524) received medication (50.6 % varenicline [n = 265] and 49.4 % bupropion [n = 259]). Reasons for not filling a prescription were failure to visit a physician (80.1 %; 95 % CI = 73.8–86.5 %; n = 121), physician not prescribing the medication (15.9 %; 95 % CI = 10.1–21.7 %; n = 24) or other reasons (4.0 %; 95 % CI = 0.9–7.1 %; n = 6). Follow-up response rate was 66.7 % (95 % CI = 63.7–69.8 %; n = 596). Minimal issues were encountered with printing the prescription or medication delivery. CONCLUSIONS: This study establishes the feasibility of using the Internet and free medication to enable smokers to engage physicians to treat this addiction. Implementation of this intervention can be scaled up by leveraging existing healthcare systems to treat smokers on a population level. Further evaluation in a randomized controlled trial is necessary. TRIAL REGISTRATION: ClinicalTrials.gov Identifier NCT01023659 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13012-015-0329-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4590254
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45902542015-10-02 Empowering smokers with a web-assisted tobacco intervention to use prescription smoking cessation medications: a feasibility trial Selby, Peter Hussain, Sarwar Voci, Sabrina Zawertailo, Laurie Implement Sci Research BACKGROUND: Varenicline and bupropion, efficacious smoking cessation medications, have had suboptimal impact due to barriers at the patient, practitioner and system level. This study explored the feasibility of a web-assisted tobacco intervention offering free prescription smoking cessation medication by mail if the smoker visited a physician for authorization. METHODS: Adult Ontarians, smoking at least 10 cigarettes daily, intending to quit within 30 days, with no contraindications to bupropion or varenicline were eligible. After an online assessment, eligible participants received an electronic personalized printable prescription form for a 12-week course of varenicline or bupropion to bring to a physician within 3 weeks for authorization, if appropriate. The physician’s office faxed prescriptions to an online pharmacy that couriered medication to the patient following medication counselling by telephone. Weekly motivational emails were sent during treatment. Participants were asked to complete follow-up questionnaires online at 7, 11, 15 and 41 weeks after enrollment. RESULTS: In total, 1214 individuals submitted an online assessment from April to September 2010 and 73.6 % (95 % confidence interval (CI) = 71.1–76.1 %; n = 893) were eligible. At least 65.8 % (95 % CI = 62.7–68.9 %; n = 588) of eligible participants subsequently visited a physician and 58.7 % (95 % CI = 55.5–61.9 %; n = 524) received medication (50.6 % varenicline [n = 265] and 49.4 % bupropion [n = 259]). Reasons for not filling a prescription were failure to visit a physician (80.1 %; 95 % CI = 73.8–86.5 %; n = 121), physician not prescribing the medication (15.9 %; 95 % CI = 10.1–21.7 %; n = 24) or other reasons (4.0 %; 95 % CI = 0.9–7.1 %; n = 6). Follow-up response rate was 66.7 % (95 % CI = 63.7–69.8 %; n = 596). Minimal issues were encountered with printing the prescription or medication delivery. CONCLUSIONS: This study establishes the feasibility of using the Internet and free medication to enable smokers to engage physicians to treat this addiction. Implementation of this intervention can be scaled up by leveraging existing healthcare systems to treat smokers on a population level. Further evaluation in a randomized controlled trial is necessary. TRIAL REGISTRATION: ClinicalTrials.gov Identifier NCT01023659 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13012-015-0329-7) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-01 /pmc/articles/PMC4590254/ /pubmed/26429100 http://dx.doi.org/10.1186/s13012-015-0329-7 Text en © Selby et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Selby, Peter
Hussain, Sarwar
Voci, Sabrina
Zawertailo, Laurie
Empowering smokers with a web-assisted tobacco intervention to use prescription smoking cessation medications: a feasibility trial
title Empowering smokers with a web-assisted tobacco intervention to use prescription smoking cessation medications: a feasibility trial
title_full Empowering smokers with a web-assisted tobacco intervention to use prescription smoking cessation medications: a feasibility trial
title_fullStr Empowering smokers with a web-assisted tobacco intervention to use prescription smoking cessation medications: a feasibility trial
title_full_unstemmed Empowering smokers with a web-assisted tobacco intervention to use prescription smoking cessation medications: a feasibility trial
title_short Empowering smokers with a web-assisted tobacco intervention to use prescription smoking cessation medications: a feasibility trial
title_sort empowering smokers with a web-assisted tobacco intervention to use prescription smoking cessation medications: a feasibility trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590254/
https://www.ncbi.nlm.nih.gov/pubmed/26429100
http://dx.doi.org/10.1186/s13012-015-0329-7
work_keys_str_mv AT selbypeter empoweringsmokerswithawebassistedtobaccointerventiontouseprescriptionsmokingcessationmedicationsafeasibilitytrial
AT hussainsarwar empoweringsmokerswithawebassistedtobaccointerventiontouseprescriptionsmokingcessationmedicationsafeasibilitytrial
AT vocisabrina empoweringsmokerswithawebassistedtobaccointerventiontouseprescriptionsmokingcessationmedicationsafeasibilitytrial
AT zawertailolaurie empoweringsmokerswithawebassistedtobaccointerventiontouseprescriptionsmokingcessationmedicationsafeasibilitytrial